AI Centre to harness newly launched Zenith AI Supercomputer to advance AI-driven healthcare innovation

At the AI Centre (AIC), we are partnering with the University of Cambridge, Cambridge University Hospitals, and NHS Trusts across the UK to harness the power of the newly launched Zenith AI Supercomputer. Our focus is on using this national-scale capability to accelerate the development and deployment of impactful healthcare AI solutions.

The launch of the Cambridge Zenith AI Supercomputer, unveiled during a visit by the Minister for Science, Innovation and Technology, marks a significant step forward for the UK’s AI infrastructure. As the country’s largest AI-for-science platform, Zenith provides the computational scale required to support advanced research and real-world clinical applications.

Through this collaboration, we are working to connect NHS data and expertise with high-performance computing infrastructure. This enables us to develop next-generation tools in predictive analytics, diagnostics, and personalised medicine. A key priority for the AI Centre is advancing cancer research through the MOSAIC (Multimodal Oncology Sovereign AI Collaboration) programme, where we are contributing to the development of NHS cancer foundation models.

Our ambition is to help establish a sovereign NHS AI capability that can be applied across a wide range of clinical use cases. This includes improving cancer diagnosis, supporting treatment selection, enhancing outcomes prediction, and enabling the development of new therapeutics. These solutions are being designed with deployment in mind, ensuring they deliver practical benefits to clinicians and patients while maintaining secure, UK-based control of sensitive health data.

The launch of Zenith brought together leaders from government, academia, and healthcare, reinforcing the importance of cross-sector collaboration. For us at the AI Centre, this partnership is a key step in bridging the gap between research innovation and frontline healthcare delivery.

As national investment in AI continues to grow, we see initiatives like Zenith as central to building the UK’s long-term capability. Our collaboration with Cambridge reflects a shared commitment to responsibly scaling AI, strengthening sovereign infrastructure, and delivering meaningful improvements in patient care and health system efficiency.